Brian Susskind

1.6k total citations
36 papers, 1.3k citations indexed

About

Brian Susskind is a scholar working on Transplantation, Immunology and Surgery. According to data from OpenAlex, Brian Susskind has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Transplantation, 14 papers in Immunology and 11 papers in Surgery. Recurrent topics in Brian Susskind's work include Renal Transplantation Outcomes and Treatments (16 papers), Organ Transplantation Techniques and Outcomes (10 papers) and Immune Cell Function and Interaction (8 papers). Brian Susskind is often cited by papers focused on Renal Transplantation Outcomes and Treatments (16 papers), Organ Transplantation Techniques and Outcomes (10 papers) and Immune Cell Function and Interaction (8 papers). Brian Susskind collaborates with scholars based in United States, Netherlands and Germany. Brian Susskind's co-authors include Göran B. Klintmalm, Paul I. Terasaki, Hugo Kaneku, Jacqueline G. O’Leary, Prabir Roy‐Chaudhury, Rita R. Alloway, E. Steve Woodle, Michael Cardi, Paul Brailey and Linda W. Jennings and has published in prestigious journals such as The Journal of Experimental Medicine, Transplantation and American Journal of Transplantation.

In The Last Decade

Brian Susskind

36 papers receiving 1.2k citations

Peers

Countries citing papers authored by Brian Susskind

Since Specialization

Citations

This map shows the geographic impact of Brian Susskind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Susskind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Susskind more than expected).

Fields of papers citing papers by Brian Susskind

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Susskind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Susskind. The network helps show where Brian Susskind may publish in the future.

Co-authorship network of co-authors of Brian Susskind

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Susskind. A scholar is included among the top collaborators of Brian Susskind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Susskind. Brian Susskind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Donor-specific alloantibodies are associated with fibrosis progression after liver transplantation in hepatitis C virus–infected patients 2014 ·Liver Transplantation ·Jacqueline G. O’Leary, Hugo Kaneku, Linda W. Jennings, Brian Susskind, Paul I. Terasaki, Göran B. Klintmalm	49
2	Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation 2013 ·Liver Transplantation ·Jacqueline G. O’Leary, Hugo Kaneku, Linda W. Jennings, Nubia Bañuelos, Brian Susskind, Paul I. Terasaki, Göran B. Klintmalm	101
3	Antibody-Mediated Rejection as a Contributor to Previously Unexplained Early Liver Allograft Loss 2013 ·Liver Transplantation ·Jacqueline G. O’Leary, Hugo Kaneku, Anthony J. Demetris, (unknown), S. Michelle Shiller, Brian Susskind, G. Weldon Tillery, Paul I. Terasaki, Göran B. Klintmalm	82
4	Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with Chronic rejection and graft loss after liver transplantation 2012 ·Liver Transplantation ·Hugo Kaneku, Jacqueline G. O’Leary, Michiko Taniguchi, Brian Susskind, Paul I. Terasaki, Göran B. Klintmalm	100
5	Implications of a positive crossmatch in liver transplantation: A 20-year review# 2011 ·Liver Transplantation ·Richard Ruiz, Koji Tomiyama, Jeffrey Campsen, Robert M. Goldstein, Marlon F. Levy, Greg J. McKenna, Nicholas Onaca, Brian Susskind, G. Weldon Tillery, Göran B. Klintmalm	33
6	A Lifetime Versus a Graft Life Approach Redefines the Importance of HLA Matching in Kidney Transplant Patients 2009 ·Transplantation ·Herwig‐Ulf Meier‐Kriesche, Juan C. Scornik, Brian Susskind, Shehzad Rehman, Jesse D. Schold	83
7	Indications for combined liver and kidney transplantation: propositions after a 23‐yr experience 2009 ·Clinical Transplantation ·Richard Ruiz, Linda W. Jennings, Peter Kim, Koji Tomiyama, Srinath Chinnakotla, Bernard Fischbach, Robert M. Goldstein, Marlon F. Levy, Greg J. McKenna, Larry B. Melton, Nicholas Onaca, Henry B. Randall, Edmund Q. Sanchez, Brian Susskind, Göran B. Klintmalm	9
8	Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection 2008 ·Transplantation ·Matthew J. Everly, J Everly, Brian Susskind, Paul Brailey, Lois J. Arend, Rita R. Alloway, Prabir Roy‐Chaudhury, Amit Govil, G. Mogilishetty, Adele Rike, Michael Cardi, George Wadih, Amit D. Tevar, E. Steve Woodle	306
9	A Significant Role for Histocompatibility in Human Islet Transplantation 2006 ·Transplantation ·T. Mohanakumar, Kishore Narayanan, Niraj M. Desai, Sabarinathan Ramachandran, Surendra Shenoy, Martin D. Jendrisak, Brian Susskind, Barbara Olack, N. Benshoff, D. Phelan, Daniel C. Brennan, Luis A. Fernandez, Jon S. Odorico, Kenneth S. Polonsky	53
10	Implications of ABO Error Rates in Proficiency Testing for Solid Organ Transplantation 2006 ·Transplantation ·Christopher Bryan, Herbert F. Polesky, A. Bradley Eisenbrey, Deborah Sesok‐Pizzini, Alan M. Luger, Douglas M. Smith, Brian Susskind	6
11	Prediction of Crossmatch Outcome of Highly Sensitized Patients by Single and/or Multiple Antigen Bead Luminex Assay 2006 ·Transplantation ·Smita Vaidya, (unknown), Brian Susskind, (unknown), Titus Barnes, (unknown)	79
12	African-American Renal Transplant Recipients Benefit from Early Corticosteroid Withdrawal Under Modern Immunosuppression 2005 ·American Journal of Transplantation ·(unknown), Rita R. Alloway, J. Wesley Alexander, (unknown), Michael Cardi, M. Roy First, Michael J. Hanaway, Rino Munda, Christin C. Rogers, Prabir Roy‐Chaudhury, Brian Susskind, Jennifer Trofe, E. Steve Woodle	29
13	Murine model of transfusion related acute lung injury (TRALI) due to anti-MHC 2003 ·Human Immunology ·Richard T. Strait, (unknown), Brian Susskind, Fred D. Finkelman	4
14	FLOW CYTOMETRY-DETECTED IgG IS NOT A CONTRAINDICATION TO RENAL TRANSPLANTATION 1999 ·Transplantation ·Ronald H. Kerman, Brian Susskind, I. Buyse, (unknown), Jim Ruth, (unknown), Scott A. Gruber, (unknown), Charles T. Van Buren, Barry D. Kahan	73
15	CAN AN IMMUNOLOGICALLY, NONREACTIVE POTENTIAL ALLOGRAFT RECIPIENT UNDERGO TRANSPLANTATION WITHOUT A DONOR-SPECIFIC CROSSMATCH?1 1998 ·Transplantation ·Ronald H. Kerman, Brian Susskind, Jim Ruth, Stephen I. Katz, Charles T. Van Buren, Barry D. Kahan	16
16	Cytolytic effector mechanisms of human CD4+ cytotoxic T lymphocytes 1996 ·Human Immunology ·Brian Susskind, (unknown), (unknown), Brian Duffy, (unknown), Jay P. Siegel, T. Mohanakumar	34
17	Immunosuppressive effect of monoclonal antibodies to ICAM‐1 and LFA‐1 on peripheral nerve allograft in mice 1995 ·Microsurgery ·Yasushi Nakao, Susan E. Mackinnon, Suzanne R. Strasberg, Martin Hertl, Mitsuaki Isobe, Brian Susskind, T. Mohanakumar, Daniel A. Hunter	12
18	Monoclonal Antibody to Tumor Necrosis Factor-α Attenuates Plasma Interleukin-6 Levels in Porcine Gram-Negative Sepsis 1994 ·Journal of Surgical Research ·Patrick G. Mullen, Bernard Fisher, Ciaran Walsh, Brian Susskind, Sandra K. Leeper-Woodford, Gary Jesmok, Alpha A. Fowler, Harvey J. Sugerman	4
19	Difluoromethylornithine (DFMO) arrests murine CTL development in the late, pre-effector stage 1991 ·Immunopharmacology ·(unknown), (unknown), (unknown), Brian Susskind	9
20	Differential sensitivity of cytotoxic T lymphocytes and lymphokine-activated killer cells to inhibition by l-ornithine 1991 ·Cellular Immunology ·Brian Susskind, (unknown), (unknown), D. Scott Lind, Harry D. Bear	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact